SCHEMBL19902802

SCHEMBL19902802

CCCc1ncccc1C(=N)Nc1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
NPC1 O15118 11/20 0.44
RAB9A P51151 10/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPT P10636 4/20 0.42
KDR P35968 1/20 0.41
SMN1; SMN2 Q16637 6/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.41
AHR P35869 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19902734 0.89 KDM4E (0.49) KDM4ENPC1RAB9ACASP3SENP8
SCHEMBL19902738 0.75 RAB9A (0.46) KDM4ENPC1RAB9AMAPTSMN1; SMN2
SCHEMBL19902747 0.74 ATM (0.46) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL19902741 0.72 KDM4E (0.52) KDM4ENPC1RAB9ACASP3SENP8
SCHEMBL11452798 0.71 NPC1 (0.48) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL4862360 0.69 KDR (0.56) KDM4ENPC1RAB9AMAPTKDR
SCHEMBL17064036 0.68 P2RX7 (0.38) KDM4ENPC1MAPTL3MBTL1MAPK1
SCHEMBL258368 0.68 KDM4E (0.53) KDM4ENPC1RAB9AMAPTSMN1; SMN2
SCHEMBL17714455 0.68 TDP1 (0.50) KDM4EMAPTSMN1; SMN2L3MBTL1MAPK1
SCHEMBL18790103 0.68 P2RX7 (0.45) KDM4ENPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033337-B1 SUBSTITUTED IMIDAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS JANSSEN PHARMACEUTICA NV (BE) 2018-02-28 EP disclosed